Axa
EYPT icon

Axa’s EyePoint Inc EYPT Stock Holding History

Axa’s Portfolio EYPT Stock Details EYPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-263,233
Closed -$2.48M – 419
2025
Q2 		$2.48M Buy
263,233
+424
+0.2% +$2.93K 0.01% 731
2025
Q1 		$1.42M Sell
262,809
-334
-0.1% -$2.34K ﹤0.01% 796
2024
Q4 		$1.96M Sell
263,143
-415
-0.2% -$3.86K 0.01% 757
2024
Q3 		$2.11M Buy
263,558
+75
+0% +$659 0.01% 732
2024
Q2 		$2.29M Buy
263,483
+148
+0.1% +$2.07K 0.01% 726
2024
Q1 		$5.44M Sell
263,335
-23,808
-8% -$589K 0.02% 540
2023
Q4 		$6.64M Sell
287,143
-6,948
-2% -$77.7K 0.02% 487
2023
Q3 		$2.35M Buy
294,091
+64,678
+28% +$709K 0.01% 683
2023
Q2 		$2M Buy
+229,413
New +$1.4M 0.01% 729

Other funds holding EYPT

CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Axa's EYPT Position: Q3 2025 in Review

Axa sold out of EyePoint Inc (EYPT) in Q3 2025, closing a stake of 263,233 shares — an estimated $2.48M sold.

Axa first reported a position in EYPT in Q2 2023 and held it in 9 quarters. The position peaked at $6.64M in Q4 2023. 151 funds tracked by Wall St. Rank hold EYPT as of Q3 2025.

  • Axa reported no remaining EyePoint Inc position as of Q3 2025 after selling out during the quarter.
  • Axa sold 263,233 EyePoint Inc shares in Q3 2025, an estimated $2.48M.
  • Axa first reported a position in EyePoint Inc in Q2 2023 and held it in 9 quarters.
  • Axa's EyePoint Inc position peaked at $6.64M in Q4 2023.
  • 151 funds tracked by Wall St. Rank held EyePoint Inc as of Q3 2025.

Based on Axa's 13F filing for Q3 2025, filed 14 Nov 2025.